{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:19:58Z","timestamp":1771705198582,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Bourse Pro-Femmes"},{"name":"Public Health Office of the canton of Vaud"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2867-x","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T07:30:54Z","timestamp":1513927854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of HPV vaccination with Gardasil\u00ae in Switzerland"],"prefix":"10.1186","volume":"17","author":[{"given":"Martine","family":"Jacot-Guillarmod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Greub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chahin","family":"Achtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-1142","authenticated-orcid":false,"given":"Roland","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"issue":"1","key":"2867_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"2","key":"2867_CR2","first-page":"101","volume":"10","author":"SK Kjaer","year":"2001","unstructured":"Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark Prev. 2001;10(2):101\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2867_CR3","first-page":"55","volume":"186","author":"MH Schiffman","year":"1994","unstructured":"Schiffman MH. Epidemiology of cervical human papillomavirus infections. Curr Top Microbiol Immunol. 1994;186:55\u201381.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"2867_CR4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813\u20139.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"2867_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25(Suppl 1):2\u201323.","journal-title":"Rev Med Virol"},{"issue":"5","key":"2867_CR6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565\u201380.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2867_CR7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.vaccine.2010.10.018","volume":"29","author":"CA Wong","year":"2011","unstructured":"Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montanez OG, Kjaer SK, et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine. 2011;29(5):878\u201385.","journal-title":"Vaccine"},{"key":"2867_CR8","unstructured":"Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study (CIN3+plus) \nhttps:\/\/www.bag.admin.ch\/bag\/fr\/home\/themen\/mensch-gesundheit\/uebertragbare-krankheiten\/infektionskrankheiten-a-z\/hpv.html\n\n."},{"issue":"38","key":"2867_CR9","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/j.vaccine.2010.07.007","volume":"28","author":"N De Carvalho","year":"2010","unstructured":"De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, Sanchez N, Schuind A. Sustained efficacy and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine. 2010;28(38):6247\u201355.","journal-title":"Vaccine"},{"issue":"9686","key":"2867_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301\u201314.","journal-title":"Lancet"},{"issue":"4","key":"2867_CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","volume":"63","author":"SM Garland","year":"2016","unstructured":"Garland SM, Kjaer SK, Munoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G, et al. Impact and effectiveness of the Quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519\u201327.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"2867_CR12","first-page":"S3\/171","volume":"24","author":"EL Franco","year":"2006","unstructured":"Franco EL, Cuzick J, Hildesheim A, de Sanjose S. Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine. 2006;24(Suppl 3):S3\/171\u20137.","journal-title":"Vaccine"},{"key":"2867_CR13","doi-asserted-by":"crossref","unstructured":"Bally F, Quach A, Greub G, Jaton K, Petignat C, Ambord C, Fellay J, Masserey E, Spencer B. Opportunistic testing for urogenital infection with chlamydia trachomatis in south-western Switzerland, 2012: a feasibility study. Euro Surveill. 2015;20(9)","DOI":"10.2807\/1560-7917.ES2015.20.9.21051"},{"issue":"Pt 12","key":"2867_CR14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1099\/jmm.0.46675-0","volume":"55","author":"K Jaton","year":"2006","unstructured":"Jaton K, Bille J, Greub G. A novel real-time PCR to detect chlamydia trachomatis in first-void urine or genital swabs. J Med Microbiol. 2006;55(Pt 12):1667\u201374.","journal-title":"J Med Microbiol"},{"issue":"2","key":"2867_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02749-13","volume":"52","author":"C Estrade","year":"2014","unstructured":"Estrade C, Sahli R. Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping. J Clin Microbiol. 2014;52(2):607\u201312.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"2867_CR16","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/JCM.05039-11","volume":"49","author":"C Estrade","year":"2011","unstructured":"Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J Clin Microbiol. 2011;49(10):3474\u201381.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2867_CR17","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JCM.01950-14","volume":"52","author":"C Estrade","year":"2014","unstructured":"Estrade C, Sahli R. Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay. J Clin Microbiol. 2014;52(11):4033\u20135.","journal-title":"J Clin Microbiol"},{"key":"2867_CR18","unstructured":"R: A language and environment for statistical computing. Vienna: Foundation for Statistical Computing. Available from: \nhttp:\/\/www.R-project.org"},{"key":"2867_CR19","unstructured":"Swiss Federal Statistical Office. Statistiques de la. Sant\u00e9. 2014; \nhttps:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/health.assetdetail.349485.html\n\n."},{"key":"2867_CR20","unstructured":"Narring F, Tschumper A, Inderwildi Bonivento L, Jeannin A, Addor V, B\u00fctikofer A, Suris J, Diserens C, Alsaker F, Michaud P. Sant\u00e9 et sytle de vie des adolescents \u00e2g\u00e9s de 16 \u00e0 20 ans en Suisse (2002). In. Lausanne: raisons de. sant\u00e9. 2004;95a"},{"issue":"33","key":"2867_CR21","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1016\/j.vaccine.2012.05.053","volume":"30","author":"AS Forster","year":"2012","unstructured":"Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine. 2012;30(33):4939\u201344.","journal-title":"Vaccine"},{"issue":"2","key":"2867_CR22","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1503\/cmaj.140900","volume":"187","author":"LM Smith","year":"2015","unstructured":"Smith LM, Kaufman JS, Strumpf EC, Levesque LE. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario grade 8 HPV vaccine cohort study. CMAJ. 2015;187(2):E74\u201381.","journal-title":"CMAJ"},{"key":"2867_CR23","volume-title":"Couverture vaccinale des \u00e9l\u00e8ves de 8e ann\u00e9e (actuellement 10e) dans le canton de Vaud","author":"V Campiche","year":"2013","unstructured":"Campiche V, Fiorini-Bernasconi C, Duperrex O: Couverture vaccinale des \u00e9l\u00e8ves de 8e ann\u00e9e (actuellement 10e) dans le canton de Vaud. In. Edited by PSPS-AVASAD U; 2013."},{"issue":"1","key":"2867_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2334-14-87","volume":"14","author":"Y Delere","year":"2014","unstructured":"Delere Y, Remschmidt C, Leuschner J, Schuster M, Fesenfeld M, Schneider A, Wichmann O, Kaufmann AM. Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis. 2014;14(1):87.","journal-title":"BMC Infect Dis"},{"issue":"3 Suppl","key":"2867_CR25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2009.06.003","volume":"115","author":"A Crochard","year":"2009","unstructured":"Crochard A, Luyts D, di Nicola S, Goncalves MA. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol. 2009;115(3 Suppl):S7\u2013S14.","journal-title":"Gynecol Oncol"},{"key":"2867_CR26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/1471-2458-12-623","volume":"12","author":"D Panatto","year":"2012","unstructured":"Panatto D, Amicizia D, Trucchi C, Casabona F, Lai PL, Bonanni P, Boccalini S, Bechini A, Tiscione E, Zotti CM, et al. Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health. 2012;12:623.","journal-title":"BMC Public Health"},{"issue":"10","key":"2867_CR27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","volume":"14","author":"SN Tabrizi","year":"2014","unstructured":"Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis. 2014;14(10):958\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2867_CR28","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/infdis\/jiv342","volume":"212","author":"EF Dunne","year":"2015","unstructured":"Dunne EF, Naleway A, Smith N, Crane B, Weinmann S, Braxton J, Steinau M, Unger ER, Markowitz LE. Reduction in human papillomavirus vaccine type prevalence among young women screened for cervical cancer in an integrated US healthcare delivery system in 2007 and 2012-2013. J Infect Dis. 2015;212(12):1970\u20135.","journal-title":"J Infect Dis"},{"issue":"3","key":"2867_CR29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1968","volume":"137","author":"LE Markowitz","year":"2016","unstructured":"Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3):e20151968.","journal-title":"Pediatrics"},{"issue":"1","key":"2867_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vaccine.2013.10.085","volume":"32","author":"D Mesher","year":"2013","unstructured":"Mesher D, Soldan K, Howell-Jones R, Panwar K, Manyenga P, Jit M, Beddows S, Gill ON. Reduction in HPV 16\/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine. 2013;32(1):26\u201332.","journal-title":"Vaccine"},{"issue":"11","key":"2867_CR31","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","volume":"110","author":"K Kavanagh","year":"2014","unstructured":"Kavanagh K, Pollock KG, Potts A, Love J, Cuschieri K, Cubie H, Robertson C, Donaghy M. Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types. Br J Cancer. 2014;110(11):2804\u201311.","journal-title":"Br J Cancer"},{"issue":"1","key":"2867_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","volume":"22","author":"RL Cameron","year":"2016","unstructured":"Cameron RL, Kavanagh K, Pan J, Love J, Cuschieri K, Robertson C, Ahmed S, Palmer T, Pollock KG. Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009-2013. Emerg Infect Dis. 2016;22(1):56\u201364.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"2867_CR33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/bjc.2014.479","volume":"111","author":"KG Pollock","year":"2014","unstructured":"Pollock KG, Kavanagh K, Potts A, Love J, Cuschieri K, Cubie H, Robertson C, Cruickshank M, Palmer TJ, Nicoll S, et al. Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer. 2014;111(9):1824\u201330.","journal-title":"Br J Cancer"},{"issue":"1","key":"2867_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6603501","volume":"96","author":"M Kohli","year":"2007","unstructured":"Kohli M, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M. Estimating the long-term impact of a prophylactic human papillomavirus 16\/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer. 2007;96(1):143\u201350.","journal-title":"Br J Cancer"},{"issue":"5","key":"2867_CR35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2015.474","volume":"114","author":"TJ Palmer","year":"2016","unstructured":"Palmer TJ, McFadden M, Pollock KG, Kavanagh K, Cuschieri K, Cruickshank M, Cotton S, Nicoll S, Robertson C. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study. Br J Cancer. 2016;114(5):582\u20139.","journal-title":"Br J Cancer"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2867-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T05:06:11Z","timestamp":1517461571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2867-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2867"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2867-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"790"}}